Medigen Biotechnology (3176) — Cash Flow Quality Index

Latest as of March 2025: -0.28x

Medigen Biotechnology (3176) has a Cash Flow Quality Index of -0.28x as of March 2025. Operating cash flow of NT$-28.96 Million is below net income of NT$102.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Medigen Biotechnology to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.28x

Operating CF / Net Income

Operating Cash Flow

NT$-28.96 Million

TWD

Net Income

NT$102.45 Million

TWD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Medigen Biotechnology (None–None)

Year-by-year earnings quality comparison for Medigen Biotechnology. For live market cap and the full company financial profile, see how much is Medigen Biotechnology worth.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.